Elite Pharma director Barry H. Dash buys 30,000 common shares for $8,610
ELTP•Director increases stake with market purchase
- Elite Pharmaceuticals director Barry H. Dash bought 30,000 common shares in a market purchase priced at $0.29 each.
- Directly held stake rose to 3,265,555 common shares following the purchase.
